Zydus and Synthon ink licensing and supply agreement for Ozanimod Capsules for US market
Under the terms of this agreement, Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product
Under the terms of this agreement, Synthon will be responsible for obtaining final regulatory approval for its Ozanimod Capsules product
Brenntag Specialties will provide pharmaceutical manufacturers and biopharmaceutical companies with a reliable supply of high-purity, GMP-compliant acetates
Approval based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death for the Imfinzi regimen vs. neoadjuvant chemotherapy alone
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
For the full financial year FY25, revenue from operations grew 9 per cent to Rs. 11,537.8 crore, compared to Rs. 10,588 crore in FY24.
Acquisition to advance company's next generation biology portfolio with internationally recognized pioneer in organoid development
The company will also share results in two additional posters for deuruxolitinib
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
Subscribe To Our Newsletter & Stay Updated